Archived
This content is available here strictly for research, reference, and/or recordkeeping and as such it may not be fully accessible. If you work or study at University of Kentucky and would like to request an accessible version, please use the SensusAccess Document Converter.
US Patent Number
9,642,908
Publication Date
5-9-2017
Abstract
Disclosed is an in vivo equine disease model and a method of preparing the disease model for equine herpesvirus-1 neurological disease comprising a horse having a low preexposure level of herpesvirus-specific CTL precursors wherein the horse is experimentally infected with a neuropathogenic strain of equine herpesvirus or a mutant thereof. Also disclosed is a method of quantifying the risk factors and predicting the development of clinical neurologic signs of equine herpesvirus-1 neurological disease in a horse. Also described in the invention is the determination of the risk of developing the clinical neurologic signs by a mathematical equation. A new live, attenuated vaccine formulation is disclosed that is effective against neurologic disease due to equine herpesvirus-1.
Assignees
University of Kentucky Research Foundation, Lexington, KY (US)
Application Number
13/054,608
Filing Date
7-29-2009
Recommended Citation
Allen, George P. and Ross, Glenda, "Equine Disease Model for Herpesvirus Neurologic Disease and Uses Thereof" (2017). Veterinary Science Faculty Patents. 17.
https://uknowledge.uky.edu/gluck_patents/17
